Trump Implements Executive Order to Accelerate Research on Psychedelic Drugs for Mental Health Treatment
18.04.2026, 18:00
In a significant move aimed at enhancing treatment options for serious mental illnesses, President Trump has signed an executive order to expedite research and access to psychedelic drugs, including controversial substances like ibogaine, psilocybin, and LSD. The order directs the FDA to fast-track...